Roivant Sciences Ltd. · NASDAQ:ROIV
Sukhatme Mayukh sold 1,000,000 Roivant Sciences Ltd. shares (Form 4)
Traded Jun 25 to Jun 26, 2026 · Filed Jun 29, 2026
From Jun 25 to Jun 26, 2026, Sukhatme Mayukh (Director, President & CIO) sold 1,000,000 Roivant Sciences Ltd. shares at an average US$34.11 for US$34.1M, leaving 18,677,617 shares. Filed Jun 29, 2026 (Form 4).
- Sold
- 1,000,000 shares
- Price
- US$34.11 average (US$34.08 to US$34.13)
- Value
- US$34.1M
- Holding after
- 18,677,617 shares
- Trading plan
- No
- Role
- Director, President & CIO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 25, 2026 | Common Shares | Option exercise | 500,000 | US$3.85 | 19,177,617 | Direct |
| Jun 25, 2026 | Common Shares | Sale | 500,000 | US$34.13 | 18,677,617 | Direct |
| Jun 26, 2026 | Common Shares | Option exercise | 500,000 | US$3.85 | 19,177,617 | Direct |
| Jun 26, 2026 | Common Shares | Sale | 500,000 | US$34.08 | 18,677,617 | Direct |
Source
Related
- Roivant Sciences Ltd.
- Sukhatme Mayukh
- Roivant Sciences Ltd. shareholders
- Form 4 · Sukhatme Mayukh · Oct 2, 2026
- Form 4 · Sukhatme Mayukh · Aug 21, 2026
- Form 4 · Sukhatme Mayukh · Aug 18, 2026
- Form 4 · Sukhatme Mayukh · Jul 2, 2026
- Form 4 · Sukhatme Mayukh · Apr 1, 2026
- Form 4 · Epperly Melissa B, · Oct 5, 2026
- Form 4 · Gline Matthew · Oct 2, 2026
- Form 4 · Venker Eric · Oct 2, 2026
- Form 4 · Torti Frank · Oct 2, 2026
- Form 4 · Pulik Richard · Sep 22, 2026